Literature DB >> 30526228

Advances in Genetic Testing in Patients With Breast Cancer, High-Quality Decision Making, and Responsible Resource Allocation.

Kara J Milliron1, Jennifer J Griggs1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30526228     DOI： 10.1200/JCO.18.01952

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.

Authors:  Padma Sheila Rajagopal; Daniel V T Catenacci; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2019-06-27       Impact factor: 44.544

2.  DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data.

Authors:  Jiaqi Liu; Hengqiang Zhao; Yu Zheng; Lin Dong; Sen Zhao; Yongxin Yang; Zhihong Wu; Zhihua Liu; Jianming Ying; Xin Wang; Yukuan Huang; Shengkai Huang; Tianyi Qian; Jiali Zou; Shu Liu; Jun Li; Zihui Yan; Yalun Li; Shuo Zhang; Xin Huang; Wenyan Wang; Yiqun Li; Jie Wang; Yue Ming; Xiaoxin Li; Zeyu Xing; Ling Qin; Zhengye Zhao; Ziqi Jia; Jiaxin Li; Gang Liu; Menglu Zhang; Kexin Feng; Jiang Wu; Jianguo Zhang; Jianzhong Su; Xiang Wang; Nan Wu
Journal:  Genome Med       Date:  2022-02-25       Impact factor: 11.117

3.  Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.

Authors:  Jenny Lin; Ravi N Sharaf; Rachel Saganty; Danyal Ahsan; Julia Feit; Andrea Khoury; Hannah Bergeron; Eloise Chapman-Davis; Evelyn Cantillo; Kevin Holcomb; Stephanie V Blank; Ying Liu; Charlene Thomas; Paul J Christos; Drew N Wright; Steven Lipkin; Kenneth Offit; Melissa K Frey
Journal:  Gynecol Oncol       Date:  2021-05-19       Impact factor: 5.304

4.  A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer.

Authors:  Rachel Starkings; Valerie Shilling; Valerie Jenkins; Lesley Fallowfield
Journal:  Breast Cancer Res Treat       Date:  2020-06-23       Impact factor: 4.872

5.  Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.

Authors:  Siddhartha Yadav; Chunling Hu; Steven N Hart; Nicholas Boddicker; Eric C Polley; Jie Na; Rohan Gnanaolivu; Kun Y Lee; Tricia Lindstrom; Sebastian Armasu; Patrick Fitz-Gibbon; Karthik Ghosh; Daniela L Stan; Sandhya Pruthi; Lonzetta Neal; Nicole Sandhu; Deborah J Rhodes; Christine Klassen; Prema P Peethambaram; Tufia C Haddad; Janet E Olson; Tanya L Hoskin; Matthew P Goetz; Susan M Domchek; Judy C Boughey; Kathryn J Ruddy; Fergus J Couch
Journal:  J Clin Oncol       Date:  2020-03-03       Impact factor: 44.544

6.  Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer.

Authors:  Edward D Esplin; Sarah M Nielsen; Sara L Bristow; Judy E Garber; Heather Hampel; Huma Q Rana; N Jewel Samadder; Neal D Shore; Robert L Nussbaum
Journal:  JCO Precis Oncol       Date:  2022-09

7.  Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.

Authors:  Julie O Culver; Yael Freiberg; Charité Ricker; Jacob G Comeaux; Emmeline Y Chang; Victoria Banerjee; Duveen Sturgeon; Ilana Solomon; Josie Kagey; Mariana G Dobre; Joseph Carey; Azadeh Carr; Stephanie Cho; Janice Lu; Irene M Kang; Ketan Patel; Alicia Terando; Jason C Ye; Ming Li; Caryn Lerman; Darcy Spicer; Maria Nelson
Journal:  Ann Surg Oncol       Date:  2022-09-26       Impact factor: 4.339

8.  Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing.

Authors:  Valerie Shilling; Susan Catt; Valerie Jenkins; Lesley Fallowfield
Journal:  Breast Cancer Res Treat       Date:  2020-08-18       Impact factor: 4.872

9.  Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.

Authors:  Abhenil Mittal; S V S Deo; Ajay Gogia; Atul Batra; Akash Kumar; Sandeep Bhoriwal; Koushik Sinha Deb; Ekta Dhamija; Sanjay Thulkar; V L Ramprasad; Olufunmilayo Olopade; Raja Pramanik
Journal:  Ann Surg Oncol       Date:  2021-10-02       Impact factor: 5.344
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.